These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 18959064)
1. [FOXP1 in B-lymphoproliferative diseases]. Mara D Lijec Vjesn; 2007 May; 129 Suppl 3():43. PubMed ID: 18959064 [No Abstract] [Full Text] [Related]
2. Atypical FOXP1 expression in malignant plasma cells that show several simultaneous translocations. Korać P; Skrtić A; Peran I; Ventura RA; Dominis M Histopathology; 2009 May; 54(6):770-1. PubMed ID: 19438754 [No Abstract] [Full Text] [Related]
3. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma. Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146 [TBL] [Abstract][Full Text] [Related]
4. Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFkappaB activity in Follicular Lymphoma. Green MR; Gandhi MK; Courtney MJ; Marlton P; Griffiths L Leuk Res; 2009 Dec; 33(12):1699-702. PubMed ID: 19487025 [TBL] [Abstract][Full Text] [Related]
5. Characterization of human FOXP1 isoform 2, using monoclonal antibody 4E3-G11, and intron retention as a tissue-specific mechanism generating a novel FOXP1 isoform. Brown PJ; Kagaya R; Banham AH Histopathology; 2008 Apr; 52(5):632-7. PubMed ID: 18312343 [No Abstract] [Full Text] [Related]
6. FoxP1: conducting the Hox symphony in spinal motor neurons. Arber S Nat Neurosci; 2008 Oct; 11(10):1122-4. PubMed ID: 18818591 [No Abstract] [Full Text] [Related]
7. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma. Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679 [TBL] [Abstract][Full Text] [Related]
8. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Haralambieva E; Adam P; Ventura R; Katzenberger T; Kalla J; Höller S; Hartmann M; Rosenwald A; Greiner A; Muller-Hermelink HK; Banham AH; Ott G Leukemia; 2006 Jul; 20(7):1300-3. PubMed ID: 16673020 [No Abstract] [Full Text] [Related]
9. [Clinical phenotype of a patient with FOXP1 deletion]. Blanco Sánchez T; Duat Rodríguez A; Cantarín Extremera V; Lapunzina P; Palomares Bralo M; Nevado Blanco J An Pediatr (Barc); 2015 Apr; 82(4):280-1. PubMed ID: 25037997 [No Abstract] [Full Text] [Related]
10. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas. Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Foxp2-expressing cells in the developing spinal cord. Morikawa Y; Hisaoka T; Senba E Neuroscience; 2009 Sep; 162(4):1150-62. PubMed ID: 19463901 [TBL] [Abstract][Full Text] [Related]
12. Allergic bronchopulmonary aspergillosis in a 2-year-old asthmatic boy with immune dysregulation, polyendocrinopathy, enteropathy, X-linked. Ohshima M; Futamura M; Kamachi Y; Ito K; Sakamoto T Pediatr Pulmonol; 2009 Mar; 44(3):297-9. PubMed ID: 19205054 [TBL] [Abstract][Full Text] [Related]
13. In search of language genes. Nat Neurosci; 2001 Nov; 4(11):1049. PubMed ID: 11687807 [No Abstract] [Full Text] [Related]
14. Talk of genetics and vice versa. Pinker S Nature; 2001 Oct; 413(6855):465-6. PubMed ID: 11586336 [No Abstract] [Full Text] [Related]
15. FOXP2 as a molecular window into speech and language. Fisher SE; Scharff C Trends Genet; 2009 Apr; 25(4):166-77. PubMed ID: 19304338 [TBL] [Abstract][Full Text] [Related]
16. Modified sound-evoked brainstem potentials in Foxp2 mutant mice. Kurt S; Groszer M; Fisher SE; Ehret G Brain Res; 2009 Sep; 1289():30-6. PubMed ID: 19596273 [TBL] [Abstract][Full Text] [Related]
17. A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias. Kreil S; Hochhaus A; Cross NC; Chase A Leuk Res; 2009 Sep; 33(9):e168-9. PubMed ID: 19464057 [No Abstract] [Full Text] [Related]
18. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders. Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006 [TBL] [Abstract][Full Text] [Related]